Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Sunrest Lifescience Limited (NSE: SUNREST), ISIN INE0PLZ01012 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
SUNREST last traded at ₹35.70 (+0.00%), with a 52-week range of ₹24.66 to ₹45.06 (as of 4 Nov 2026).
Shareholding as of Sep 2026: promoters 53.50%, FIIs 0.00%, DIIs 0.00%, mutual funds 0.00%.
EquiSense Score (ECS): 58/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.